TET2 and acute lymphoblastic leukemia: Like all pediatric malignancies, T-ALL has a low mutational burden, but nonetheless, pediatric T-cell malignancies must overcome the same barriers to transformation as clearly facilitated by TET2 loss in adult T-cell malignancies.